194 related articles for article (PubMed ID: 22644068)
1. High acceptability of a vaginal ring intended as a microbicide delivery method for HIV prevention in African women.
van der Straten A; Montgomery ET; Cheng H; Wegner L; Masenga G; von Mollendorf C; Bekker L; Ganesh S; Young K; Romano J; Nel A; Woodsong C
AIDS Behav; 2012 Oct; 16(7):1775-86. PubMed ID: 22644068
[TBL] [Abstract][Full Text] [Related]
2. Safety of a silicone elastomer vaginal ring as potential microbicide delivery method in African women: A Phase 1 randomized trial.
Nel A; Martins J; Bekker LG; Ramjee G; Masenga G; Rees H; van Niekerk N
PLoS One; 2018; 13(5):e0196904. PubMed ID: 29813074
[TBL] [Abstract][Full Text] [Related]
3. Perspectives from Young South African and Zimbabwean Women on Attributes of Four (Placebo) Vaginal Microbicide Delivery Forms.
Weinrib R; Browne EN; Shapley-Quinn MK; van der Straten A; Beksinska M; Mgodi N; Musara P; Mphili N; Schwartz JL; Ju S; Hanif H; Montgomery ET;
AIDS Behav; 2020 Feb; 24(2):637-647. PubMed ID: 31254190
[TBL] [Abstract][Full Text] [Related]
4. The relationship between vaginal ring use and intimate partner violence and social harms: formative research outcomes from the CHARISMA study in Johannesburg, South Africa.
Hartmann M; Palanee-Phillips T; O'Rourke S; Adewumi K; Tenza S; Mathebula F; Wagner D; Ayub A; Montgomery ET
AIDS Care; 2019 Jun; 31(6):660-666. PubMed ID: 30309246
[TBL] [Abstract][Full Text] [Related]
5. Vaginal ring adherence in sub-Saharan Africa: expulsion, removal, and perfect use.
Montgomery ET; van der Straten A; Cheng H; Wegner L; Masenga G; von Mollendorf C; Bekker L; Ganesh S; Young K; Romano J; Nel A; Woodsong C
AIDS Behav; 2012 Oct; 16(7):1787-98. PubMed ID: 22790902
[TBL] [Abstract][Full Text] [Related]
6. Intravaginal practices and microbicide acceptability in Papua New Guinea: implications for HIV prevention in a moderate-prevalence setting.
Vallely A; Fitzgerald L; Fiya V; Aeno H; Kelly A; Sauk J; Kupul M; Neo J; Millan J; Siba P; Kaldor JM
BMC Res Notes; 2012 Nov; 5():613. PubMed ID: 23116431
[TBL] [Abstract][Full Text] [Related]
7. Impact of the Dapivirine Vaginal Ring on Sexual Experiences and Intimate Partnerships of Women in an HIV Prevention Clinical Trial: Managing Ring Detection and Hot Sex.
Laborde ND; Pleasants E; Reddy K; Atujuna M; Nakyanzi T; Chitukuta M; Naidoo S; Palanee-Phillips T; Baeten JM; Montgomery ET;
AIDS Behav; 2018 Feb; 22(2):437-446. PubMed ID: 29151197
[TBL] [Abstract][Full Text] [Related]
8. Self-reported removal and expulsion of the dapivirine vaginal ring: qualitative reports from female ring users and their male partners in the Ring Study (IPM 027).
Milford C; Ramlal H; Mofokeng R; Rambally Greener L; Nel A; Smit J; Malherbe M
BMC Public Health; 2024 May; 24(1):1458. PubMed ID: 38822304
[TBL] [Abstract][Full Text] [Related]
9. Perceptions of acceptability and utility of microbicides in Ghana, West Africa: a qualitative, exploratory study.
Tanner AE
SAHARA J; 2008 Apr; 5(1):11-8. PubMed ID: 18496615
[TBL] [Abstract][Full Text] [Related]
10. Acceptability and performance of a nonwoven device for vaginal drug delivery among women and their male partners in KwaZulu-Natal, South Africa.
Hart CW; Joanis C; Hartmann M; Milford C; Smit J; Beksinska M; Rambally-Greener L; Pienaar J; Mabude Z; Butterworth GAM; Sokal D; Jenkins D
Eur J Contracept Reprod Health Care; 2019 Oct; 24(5):390-398. PubMed ID: 31517545
[No Abstract] [Full Text] [Related]
11. The role of partnership dynamics in determining the acceptability of condoms and microbicides.
Montgomery CM; Lees S; Stadler J; Morar NS; Ssali A; Mwanza B; Mntambo M; Phillip J; Watts C; Pool R
AIDS Care; 2008 Jul; 20(6):733-40. PubMed ID: 18576176
[TBL] [Abstract][Full Text] [Related]
12. Engaging male partners in women's microbicide use: evidence from clinical trials and implications for future research and microbicide introduction.
Lanham M; Wilcher R; Montgomery ET; Pool R; Schuler S; Lenzi R; Friedland B
J Int AIDS Soc; 2014; 17(3 Suppl 2):19159. PubMed ID: 25224618
[TBL] [Abstract][Full Text] [Related]
13. Acceptability of a microbicide among women and their partners in a 4-country phase I trial.
Bentley ME; Fullem AM; Tolley EE; Kelly CW; Jogelkar N; Srirak N; Mwafulirwa L; Khumalo-Sakutukwa G; Celentano DD
Am J Public Health; 2004 Jul; 94(7):1159-64. PubMed ID: 15226137
[TBL] [Abstract][Full Text] [Related]
14. Male Partner Influence on Women's HIV Prevention Trial Participation and Use of Pre-exposure Prophylaxis: the Importance of "Understanding".
Montgomery ET; van der Straten A; Stadler J; Hartmann M; Magazi B; Mathebula F; Laborde N; Soto-Torres L
AIDS Behav; 2015 May; 19(5):784-93. PubMed ID: 25416076
[TBL] [Abstract][Full Text] [Related]
15. Men's Sexual Experiences with the Dapivirine Vaginal Ring in Malawi, South Africa, Uganda and Zimbabwe.
Montgomery ET; Katz AWK; Duby Z; Mansoor LE; Morar NS; Naidoo K; Tsidya M; Chitukuta M; Guma V; Tenza S; Leslie J; Garcia M; Naidoo S
AIDS Behav; 2021 Jun; 25(6):1890-1900. PubMed ID: 33389318
[TBL] [Abstract][Full Text] [Related]
16. Prevention, Partners, and Power Imbalances: Women's Views on How Male Partners Affected Their Adherence to Vaginal Microbicide Gels During HIV Prevention Trials in Africa.
Miller L; Morar N; Kapiga S; Ramjee G; Hayes R
J Acquir Immune Defic Syndr; 2020 Dec; 85(4):458-465. PubMed ID: 33136745
[TBL] [Abstract][Full Text] [Related]
17. Acceptability of an extended duration vaginal ring for HIV prevention and interest in a multi-purpose ring.
Stoner MCD; Browne EN; Gundacker HM; Hawley I; Chen BA; Hoesley C; Scheckter R; Piper J; Singh D; Song M; Liu A; van der Straten A
PLoS One; 2022; 17(2):e0263664. PubMed ID: 35192655
[TBL] [Abstract][Full Text] [Related]
18. To tell or not to tell: male partner engagement in a Phase 3 microbicide efficacy trial in South Africa.
Kelly CA; Friedland BA; Morar NS; Katzen LL; Ramjee G; Mokgatle MM; Ahmed K
Cult Health Sex; 2015; 17(8):1004-20. PubMed ID: 25913101
[TBL] [Abstract][Full Text] [Related]
19. Optimizing HIV prevention for women: a review of evidence from microbicide studies and considerations for gender-sensitive microbicide introduction.
Doggett EG; Lanham M; Wilcher R; Gafos M; Karim QA; Heise L
J Int AIDS Soc; 2015; 18(1):20536. PubMed ID: 26700845
[TBL] [Abstract][Full Text] [Related]
20. Relationship Type and Use of the Vaginal Ring for HIV-1 Prevention in the MTN 020/ASPIRE Trial.
Pleasants E; Tauya T; Reddy K; Mirembe BG; Woeber K; Palanee-Phillips T; Zimba C; Atujuna M; Montgomery ET;
AIDS Behav; 2020 Mar; 24(3):866-880. PubMed ID: 31111297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
